Skip to main content

Table 4 Focus genes in expression profiles of breast cancer outcome

From: Integrated analysis of independent gene expression microarray datasets improves the predictability of breast cancer outcome

Unigene

Symbol

Full name

Combined (count/rank)

Rosetta (count/rank)

Stanford (count/rank)

Hs.469649

BUB1

BUB1 budding uninhibited by benzimidazoles 1 homolog

3/9,681

24/6,547

11/8,047

Hs.576154

LRP8

low density lipoprotein receptor-related protein 8

13/8,428

60/4,211

50/3,858

Hs.496068

PCTK1

PCTAIRE protein kinase 1

1/9,862

5/8,768

120/2,261

Hs.523468

SCUBE2

signal peptide, CUB domain, EGF-like 2

2/9,732

1/9,991

3,615/1

Hs.523836

GSTP1

glutathione S-transferase pi

228/989

>3,257/0

1/9,866

Hs.208124

ESR1

estrogen receptor 1

4/9,647

248/1,048

2/9,297

Hs.58974

CCNA2

cyclin A2

9/8,673

698/149

4/8,925

Hs.524134

GATA3

GATA binding protein 3

10/8,651

99/2,755

25/5,530

Hs.82906

MPL

Myeloproliferative leukaemia virus oncogene

12/8,466

120/2,329

67/3,606

Hs.267659

VAV3

vav 3 oncogene

14/8,415

284/881

20/6,421

Hs.12272

BECN1

beclin 1 (coiled-coil, myosin like BCL2 interacting protein)

18/8,158

74/3,603

96/2,560

Hs.153752

CDC25B

cell division cycle 25B

24/7,690

37/5,249

127/2,140

Hs.9589

UBQLN1

ubiquilin 1

25/7,634

7/8,723

824/145

Hs.150749

BCL2

B-cell CLL/lymphoma 2

30/7,047

750/126

13/8,003

Hs.69771

CFB

Complement factor B

60/5,168

320/738

35/4,561

Hs.182385

HPN

hepsin (transmembrane protease, serine 1)

1,103/16

>3,257/0

60/3,685

  1. Count: how many times a gene was ranked within top-100 by 10,000 re-samplings; Rank: rank of the gene based on its count.